Question 1

What is LOPJLB’s current signal on ATRA?

Accepted Answer

LOPJLB’s latest quantitative signal on Atara Biotherapeutics, Inc. (ATRA) is SELL in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is ATRA in?

Accepted Answer

Atara Biotherapeutics, Inc. (ATRA) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Atara Biotherapeutics, Inc. (ATRA) do?

Accepted Answer

Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3…

Question 4

Where is Atara Biotherapeutics, Inc. based / listed?

Accepted Answer

Atara Biotherapeutics, Inc. is based in US, listed on NASDAQ.

Atara Biotherapeutics, Inc. (ATRA)

Key stats

Industry peers

Prediction markets

Company news